4//SEC Filing
Culwell Kelly 4
Accession 0001618835-20-000096
CIK 0001618835other
Filed
Apr 30, 8:00 PM ET
Accepted
May 1, 8:12 PM ET
Size
6.2 KB
Accession
0001618835-20-000096
Insider Transaction Report
Form 4
Culwell Kelly
Chief Medical Officer
Transactions
- Sale
Common Stock
2020-04-30$4.66/sh−1,000$4,660→ 195,226 total - Sale
Common Stock
2020-05-01$4.75/sh−1,000$4,750→ 194,226 total
Footnotes (1)
- [F1]These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 25, 2019.
Documents
Issuer
Evofem Biosciences, Inc.
CIK 0001618835
Entity typeother
Related Parties
1- filerCIK 0001726183
Filing Metadata
- Form type
- 4
- Filed
- Apr 30, 8:00 PM ET
- Accepted
- May 1, 8:12 PM ET
- Size
- 6.2 KB